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5-Formylcytosine (5fC) is a rare base found in mammalian 
DNA and thought to be involved in active DNA demethylation. 
Here, we show that developmental dynamics of 5fC levels in 
mouse DNA differ from those of 5-hydroxymethylcytosine 
(5hmC), and using stable isotope labeling in vivo, we show that 
5fC can be a stable DNA modification. These results suggest 
that 5fC has functional roles in DNA that go beyond being a 
demethylation intermediate. 
DNA of all mammalian cells and tissues is methylated at specific 
loci, mainly in the 5′-cytosine-phosphate-guanine-3′ (CpG) context, 
to modulate the expression of genes1. 5-Methylcytosine (5mC) is pro-
duced from cytosine (C) by dedicated DNA methyltransferases using 
S-adenosylmethionine (SAM) as a source of the methyl group2. In 
2009, two independent laboratories found that 5-hydroxymethyl-
cytosine (5hmC) is present in mammalian DNA and is the product 
of ten-eleven translocation (TET) enzyme–mediated oxidation 
of 5mC3,4. This oxidized base occurs in all mammalian cells and 
tissues with global levels ranging between 0.005% and 0.7% of all 
Cs5,6. The iron(II)- and 2-oxoglutarate-dependent TET enzymes can 
also oxidize 5hmC further to 5fC and 5-carboxycytosine (5caC), 
which were found at levels below 0.002% (or 20 p.p.m.) of all Cs in 
the genomic DNA of mouse embryonic stem (mES) cells and several 
adult mouse tissues7–9.
One proposed role for these oxidized cytosine bases is to serve as 
intermediates of enzyme-mediated DNA demethylation initiated by 
oxidation of 5mC10,11. Indeed, thymine-DNA glycosylase (TDG) can 
selectively recognize and excise 5fC and 5caC from the genome and 
trigger a repair process, which can lead to restoration of unmodi-
fied C7,12. Moreover, mES cells lacking TDG show increased levels 
of 5fC and 5caC, suggesting that a proportion of these modifica-
tions is constantly being removed from the genome of mES cells7,12. 
On the other hand, we recently demonstrated that 5hmC is a pre-
dominantly stable modification in mammalian DNA, especially in 
the adult mouse brain where 5hmC is most abundant6. Herein we 
investigate the temporal dynamics of 5fC in genomic DNA in vivo 
to consider whether this rare modification may be stable, rather 
than an active demethylation intermediate (Fig. 1a).
We first analyzed global levels of all cytosine modifications in the 
genomic DNA of C57BL/6 mouse tissues to see whether we could 
detect and quantify 5fC and identify a relationship between its levels 
and those of its precursors 5mC and 5hmC or its metabolite 5caC. 
We included a range of postnatal tissues from newborn (1 d old), 
adolescent (21 d old) and adult (15 week old) mice, as their genomic 
DNA is known to have different levels of 5hmC depending on the 
overall proliferation rate (and therefore the age) of the tissue6. We 
also included C57BL/6 embryos at 11.5 d post-fertilization as this 
is the lethal age for mice lacking TDG13,14, and mES cells derived 
from the same strain were added for comparison. To achieve 
quantification of the rare modifications (5fC and 5caC) with the 
highest possible sensitivity and accuracy, we employed a nano high- 
performance liquid chromatography–tandem high-resolution mass 
spectrometry (nanoHPLC-MS/HRMS) method, which is able to 
resolve genuine rare modified bases (5fC and 5caC) from poten-
tial impurities of the same nominal mass and retention time, and 
can detect down to 0.1 p.p.m. of total Cs in as little as 100 ng of 
digested genomic DNA. In addition, the use of isotopically labeled 
internal standards (IS) of C, 5mC and 5hmC substantially improved 
the quality of the measurements, ensured excellent reproducibil-
ity between technical replicates and excluded spontaneous oxida-
tion of 5hmC as the source of 5fC or 5caC. Example mass spectra, 
extracted ion chromatograms and calibration curves are shown in 
Supplementary Results, Supplementary Figures 1–5. 5mC and 
5hmC were present in all tissues (Supplementary Fig. 6), and 
the levels that we detected were in good agreement with available 
published data5,6,8,9. While 5mC levels show a relatively uniform 
distribution between tissues, global 5hmC content is highly cor-
related to the proportion of proliferating cells in the tissue, as we 
have shown previously6. We found 5fC to be also present in all 
studied tissues at levels ranging between 0.2 p.p.m. and 15 p.p.m. of 
all Cs (Fig. 1b and Supplementary Fig. 6). Notably, 5caC was not 
detected in any postnatal tissues from C57BL/6 mice, even in those 
with high 5fC content, but several tissues from C57BL/6 embryos 
(Fig. 1b) and adult (12 week old) CD1 mice (Supplementary Fig. 7) 
contained up to 2 p.p.m. of this rare DNA base modification. 
Overall, we found no correlation between the levels of 5fC and the 
levels of its precursors 5mC or 5hmC (Supplementary Fig. 8), nor 
did we find any clear pattern of DNA modification changes as the 
tissues age. They can retain the levels of 5fC while gaining 5hmC 
(e.g., brain), lose 5fC while retaining the levels of 5hmC (e.g., 
heart), or even lose 5fC while gaining 5hmC (e.g., liver) (Fig. 1c–e). 
We found that DNA from mES cells lacking all three TET enzymes 
(TET triple-knockout (TET-TKO))15 contained no detectable 
5hmC, 5fC or 5caC (Fig. 1a and Supplementary Fig. 6), con-
firming that 5hmC is the only source of 5fC and 5caC in mES cell 
DNA. Although we have no measure of tissue-specific suscepti-
bility to oxidation (such as the quantity of the oxidative lesion 
8-oxoguanine), the lack of correlation between global levels of 
5hmC and 5fC (Supplementary Fig. 8) together with the lack of 
positional overlap between 5hmC and 5fC in mES cells16,17 strongly 
suggest that 5fC and 5caC are not generated by spontaneous oxida-
tion of 5hmC and 5fC.
To elucidate the stability of 5fC in genomic DNA toward turn-
over in vivo, we applied a stable isotope tracing method consisting of 
feeding cultured cells and mice with [methyl-13CD3]L-methionine, 
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as we have done previously to study the lifetime of 5hmC6. The 
methyl-13CD3 group enters the intracellular pool of SAM and is 
transferred into newly methylated Cs by the action of DNA methyl-
transferase (DNMT) enzymes. The TET enzymes can then 
convert labeled [methyl-13CD3]5mC (5mC[+4]) into [hydroxymethyl-
13CD2]5hmC (5hmC[+3]) and [formyl-13CD]5fC (5fC[+2]) (Fig. 1a). 
The labeling ratios (e.g., % 5fC[+2] over total 5fC) change according 
to the dynamics and half-life of the given modification in the genomic 
DNA. For example, a modification that is quickly turning over in DNA 
would show a high labeling ratio, whereas a very stable modification 
would show no labeling in nonproliferating cells or tissues. The 
maximum obtainable ratio also depends on the activity of other 
biosynthetic pathways feeding into the one-carbon metabolism. The 
labeling ratios can be determined very accurately for each modified 
C using LC-MS/HRMS due to unique masses of the labeled base 
fragments (Supplementary Fig. 9 and Supplementary Table 1).
We first cultured mES cells in the labeled ([methyl-13CD3] 
L-methionine) medium for 8 d, and found that the labeling ratio 
of 5fC increased much more slowly than that of 5mC and 5hmC. 
This indicates either a substantial time lag in making 5fC from 
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Figure 1 | Dynamics of global levels of 5fC during mouse development are distinct from those of 5hmC. (a) Metabolism of cytosine modifications in dnA. 
Although the majority of 5mc and 5hmc was known to persist in the genomic dnA, the stability of 5fc and 5cac in vivo was unknown. Feeding [methyl-
13cd3]l-methionine can be used as a means to measure the lifetime of cytosine modifications in cells and in vivo. labeling pattern is indicated in red. See also 
Figure 2. (b) Global levels of 5fc and 5cac in genomic dnA from mouse embryos (embryonic day 11.5, e11.5). Shown are mean ± s.e.m. of three animals. 
each sample was analyzed in technical duplicate and the mean value was used. Wt, wild type. (c–e) changes of global 5fc (c), 5mc (d) and 5hmc (e) levels 
during development in selected c57bl/6 mouse tissues (further data in Supplementary Fig. 6). Shown are mean ± s.e.m. of three embryos (e11.5) (data 
from Fig. 1b), three newborns (1 d old), and two adolescent (21 d old) and two adult (15 week old) mice. See also Supplementary Figures 7 and 8.
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Figure 2 | 5fC can be a stable DNA modification in vivo. (a) labeling ratios of 5mc, 5hmc and 5fc in the genomic dnA of meS cells cultured in the 
presence of [methyl-13cd3]l-methionine. Shown are single measurements; total labeling time is given in brackets. (b–d) labeling ratios of 5mc, 5hmc and 
5fc in the genomic dnA of c57bl/6 mice fed with the [methyl-13cd3]l-methionine diet. (b) 6-d-old pups labeled from 1 week before birth (total labeling 
time of 13 d) or 1-d-old newborns (total labeling time of 22 d, parents on labeled diet for 52 d before conception). Shown are mean ± s.e.m. of two animals 
(6 d old pups) or two technical replicates (1 d old pup). (c,d) Mice labeled in adulthood. Shown are mean ± s.e.m. of at least two technical replicates 
from individual mice, and total labeling time is shown in brackets. the absence of 5fc[+2] in the brain (d), where 5fc is most abundant (see Fig. 1 and 
Supplementary Fig. 6), indicates minimal or no further generation of 5fc once placed in postmitotic tissues. Moreover, if 5fc was involved in cycles of 
methylation and demethylation, its labeling ratio would be similar to that of 5mc in RnA (d). See also Supplementary Figure 9 and Supplementary Table 1.
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newly formed 5hmC or the presence of a population of more 
slowly dividing or nondividing (unlabeled) cells with higher global 
levels of 5fC than the quickly dividing (labeled) population of 
mES cells (Fig. 2a).
We then analyzed genomic DNA from C57BL/6 mice fed with a 
diet in which all L-methionine was replaced with [methyl-13CD3]L-
methionine. To gain information about 5fC in developing tissues, 
we fed a pregnant female the labeled diet starting from 7 d before 
birth, and kept the family on the diet for 6 more days (so that the 
6-d-old pups had been labeled for 13 d when their tissues were 
harvested). The genomic DNA in tissues such as kidney or colon 
showed uniform labeling of around 30% for all detectable modi-
fications (5mC, 5hmC and 5fC) (Fig. 2b). However, brain tissue 
from the same pups showed much less 5hmC[+3] and no detectable 
5fC[+2]. This indicates that 5fC was formed in these tissues before 
the start of labeling and remained there for 13 d until the DNA 
was harvested. 1-d-old newborns labeled from conception and with 
prelabeled parents (starting 52 d before conception, so that total 
labeling time of pup was 22 d) already showed higher 5fC labeling 
in the brain, but the ratio was still lower than those of 5mC and 
5hmC (27% vs. 44% and 42.5%, respectively) (Fig. 2b). During the 
gestation period, the labeling ratio of the methionine pool in the 
pregnant female was still increasing, and therefore this observation 
is consistent with 5fC being more abundant in the older or more 
slowly proliferating DNA, as we concluded above. Proliferating 
tissues (e.g., spleen) from adult mice showed a similar trend in 
which the 5fC labeling ratio was always smaller than that of 5mC 
or 5hmC, even in animals labeled for as long as 4 months (117 d) 
(Fig. 2c). This effect is best explained by 5fC being mostly stable, 
and again by the presence of nondividing (unlabeled) cells 
alongside a population of proliferating (labeled) cells that have 
lower global 5fC levels than the nondividing cells.
Finally, in the mostly nondividing adult brain, where 5fC is most 
abundant (see Fig. 1 and Supplementary Fig. 6) and only 1.3% and 
3.7% of 5mC becomes labeled during the 117-d feeding period, 
there was no detectable labeled 5fC. Again, this is not due to the lack 
of an intracellular pool of [methyl-13CD3]SAM, as we could measure 
more than 50% [methyl-13CD3]5mC in RNA in adult brain and cer-
ebellum (Fig. 2d). If 5fC was a short-lived DNA modification and 
was constantly being turned over, its labeling ratio would be close to 
the labeling ratio of intracellular SAM and 5mC in RNA. If 5fC was 
short-lived and produced only from pre-existing unlabeled 5hmC 
in the adult brain, the levels of 5hmC would be depleted over time, 
which is inconsistent with the high levels of 5hmC in this tissue 
and is the opposite of what has been described for aging brain18. 
Therefore, the lack of 5fC labeling in the adult brain means that this 
modified base must be stable in the genome as opposed to generally 
acting as a dynamic intermediate of active DNA demethylation.
In summary, we present the first direct evidence that 5fC 
(derived from mC by TET-mediated oxidation) can be a stable 
DNA modification in vivo, and provide quantitative measure-
ments of the levels of all modified Cs in mouse tissues across several 
developmental stages. 5fC levels do not correlate with those of its 
precursors 5mC and 5hmC or its metabolite 5caC or with the age 
of the individual. Although there is precedent for removal of 5fC 
and 5caC from the genome (for example, in mES cells), probably in 
the process of active DNA demethylation7,12, our findings suggest 
that the bulk of 5fC can be stable. 5fC has been identified as having 
more protein binders than 5mC or 5hmC19,20 and having a genomic 
profile distinct from those of 5mC, 5hmC or 5caC at single-base 
resolution12,16,17,21–23. Moreover, 5fC has recently been shown to alter 
the structure of the DNA double helix24. We therefore conclude that 
such stably 5fC-modified DNA could have profound consequences 
for the regulation of gene expression that may be distinct to those 
caused by 5mC and 5hmC. However, direct evidence regarding the 
biological function of 5fC remains to be demonstrated. 
received 23 february 2015; accepted 15 may 2015; 
published online 22 June 2015
Methods
Methods and any associated references are available in the online 
version of the paper.
references
1. Ooi, S.K., O’Donnell, A.H. & Bestor, T.H. J. Cell Sci. 122, 2787–2791 (2009).
2. Goll, M.G. & Bestor, T.H. Annu. Rev. Biochem. 74, 481–514 (2005).
3. Kriaucionis, S. & Heintz, N. Science 324, 929–930 (2009).
4. Tahiliani, M. et al. Science 324, 930–935 (2009).
5. Globisch, D. et al. PLoS ONE 5, e15367 (2010).
6. Bachman, M. et al. Nat. Chem. 6, 1049–1055 (2014).
7. He, Y.F. et al. Science 333, 1303–1307 (2011).
8. Ito, S. et al. Science 333, 1300–1303 (2011).
9. Pfaffeneder, T. et al. Nat. Chem. Biol. 10, 574–581 (2014).
10. Song, C.X. & He, C. Trends Biochem. Sci. 38, 480–484 (2013).
11. Schiesser, S. et al. J. Am. Chem. Soc. 135, 14593–14599 (2013).
12. Neri, F. et al. Cell Reports 10, 674–683 (2015).
13. Cortázar, D. et al. Nature 470, 419–423 (2011).
14. Cortellino, S. et al. Cell 146, 67–79 (2011).
15. Hu, X. et al. Cell Stem Cell 14, 512–522 (2014).
16. Booth, M.J., Marsico, G., Bachman, M., Beraldi, D. & Balasubramanian, S. 
Nat. Chem. 6, 435–440 (2014).
17. Song, C.X. et al. Cell 153, 678–691 (2013).
18. Kraus, T.F., Guibourt, V. & Kretzschmar, H.A. J. Neural Transm.  
doi:10.1077j/s00702-014-1346-4 (2014).
19. Iurlaro, M. et al. Genome Biol. 14, R119 (2013).
20. Spruijt, C.G. et al. Cell 152, 1146–1159 (2013).
21. Booth, M.J. et al. Science 336, 934–937 (2012).
22. Yu, M. et al. Cell 149, 1368–1380 (2012).
23. Lu, X. et al. Cell Res. 25, 386–389 (2015).
24. Raiber, E.A. et al. Nat. Struct. Mol. Biol. 22, 44–49 (2015).
acknowledgments
We thank C. d’Santos and D. Oxley for their support with mass spectrometry and  
G. Xu for kindly providing TET-TKO mES cells. This work was supported by 
Cancer Research UK (C14303/A17197, S.B.), The Wellcome Trust (WT099232, S.B.; 
WT095645/Z/11/Z, W.R.) and the Biotechnology and Biological Sciences Research 
Council UK (BB/K010867/1, W.R.).
author contributions
M.B., S.U.-L. and S.B. conceived the study; S.U.-L., M.B., H.E.B. and M.I. performed 
experiments; M.B. and X.Y. carried out mass spectrometry and data analysis; S.B., A.M. 
and W.R. supervised the project; M.B. and S.B. wrote the manuscript with contributions 
from all authors.
Competing financial interests
The authors declare competing financial interests: details accompany the online version 
of the paper.
additional information
Supplementary information is available in the online version of the paper. Reprints and 
permissions information is available online at http://www.nature.com/reprints/index.
html. Correspondence and requests for materials should be addressed to S.B.
nature CHeMICaL BIOLOGY doi:10.1038/nchembio.1848
oNliNe meTHoDS
Animals. All in vivo experiments were performed under the terms of a UK 
Home Office license. C57BL/6 and CD1 mice were bred and housed accord-
ing to UK Home Office guidelines. Custom L-methionine-free mouse diet 
supplemented with [methyl-13CD3]L-methionine (Sigma) was manufactured 
by TestDiet.
Cell culture. mES cells were derived by X. Zou at the CRUK Cambridge 
Institute from a C57BL/6 mouse (Charles River) and cultured on a gelatin-
coated plate in a DMEM-KO medium (Invitrogen) supplemented with 10% 
FCS, MEM non-essential amino acids, glutamine, sodium pyruvate, penicil-
lin, streptomycin, mouse leukemia inhibitory factor (mLIF) and 2i (mitogen-
activated protein kinase kinase (MEK) and glycogen synthase kinase (GSK-3b) 
inhibitors) as described by Ying et al.25. TET-TKO mES cells were obtained 
from G. Xu15 and cultured in the 2i conditions as above. All cells were regu-
larly tested for mycoplasma contamination. For isotopic labeling experiments, 
cells were maintained in a custom L-methionine-free DMEM-KO medium 
(Invitrogen) supplemented with 30 mg/L of [methyl-13CD3]L-methionine 
(Cambridge Isotope) and the respective components above.
Genomic DNA extraction. Tissues and cells were resuspended in lysis buffer 
(100 mM Tris, pH 5.5, 5 mM EDTA, 200 mM NaCl, 0.2% SDS) supplemented 
with 400 μg/ml proteinase K (Invitrogen), and were incubated at 55 °C over-
night. DNA was purified using phenol:chloroform:isoamyl alcohol (25:24:1, 
Sigma) and Phase Lock Gel (5 Prime), precipitated from 70% ethanol and 
resuspended in ultrapure HPLC-grade water.
DNA degradation to 2′-deoxynucleosides and LC-MS analysis. 1–2 μg 
of DNA was incubated with 5 U of DNA Degradase Plus (Zymo Research) 
in a total volume of 30 μl for 4 h at 37 °C. Samples were filtered through 
 a pre-washed Amicon 10 kDa centrifugal filter unit (Millipore) before 
LC-MS analysis.
LC-MS analysis of global 5mC, 5hmC, 5fC and 5caC levels. Analysis of 
global levels of 5mC, 5hmC, 5fC and 5caC was performed on a Q Exactive 
mass spectrometer (Thermo) fitted with an UltiMate 3000 RSLCnano HPLC 
(Dionex) and a self-packed hypercarb column (20 mm × 75 μm, 3 μm par-
ticle size) at a flow rate of 0.75 μl/min and a gradient of 0.1% formic acid in 
water and acetonitrile. Calibration curves were generated using a mixture of 
synthetic standards 2′-deoxycytidine (Sigma), 5-methyl-, 5-hydroxymethyl-, 
5-formyl- and 5-carboxy-2′-deoxycytidine (Berry & Associates), in the ranges 
of 0.5 nM–5 μM for C, 0.025–50 nM for 5mC and 0.005–50 nM for 5hmC, 
5fC and 5caC. Samples and synthetic standards were spiked with an isotopi-
cally labeled mix containing 100 nM of 2′-deoxycytidine-(15N,d2) (synthesis 
and characterization in Bachman et al.6), 5-methyl-2′-deoxycytidine-(d3) 
and 5-hydroxymethyl-2′-deoxycytidine-(d3) (both from Toronto Research 
Chemicals). Target ions were fragmented in a positive ion mode at 10% 
normalized collision energy, and full scans (50–300 Da) were acquired. The 
inclusion list contained the following masses: C (228.1), C_IS (231.1), 5mC 
(242.1), 5mC_IS (245.1), 5hmC (258.1), 5hmC_IS (261.1), 5fC (256.1), 5caC 
(272.1). Extracted ion chromatograms of base fragments (see Supplementary 
Fig. 1) were used for quantification. Results are expressed as a % or p.p.m. of 
total cytosines.
LC-MS analysis of isotope incorporation into genomic DNA. Analysis of 
isotope incorporation into DNA was performed using the same instrumental 
set up as above, targeting ions of masses 242.1 (mC), 246.1 (mC[+4]), 258.1 
(5hmC and 5fC[+2]), 261.1 (5hmC[+3]) and 256.1 (5fC). Extracted ion chro-
matograms of base fragments were used for quantification of labeling ratios 
(see also Supplementary Fig. 8). Results are expressed as % labeling (for exam-
ple, % 5fC[+2] represents the percentage of labeled 5fC[+2] in total 5fCs).
LC-MS analysis of isotope incorporation into 5mC in RNA. Total RNA was 
carried through during genomic DNA extraction (no RNase treatment), dur-
ing hydrolysis to nucleosides and LC-MS/HRMS analysis. An additional mass 
of 262.1 was targeted for RNA 5mC[+4] (unlabeled 5mC was present in the 
258.1 channel), and base fragments 126.0662 (5mC) and 130.0884 (5mC[+4]) 
were used for quantification of % labeling as above.
25. Ying, Q.L. et al. Nature 453, 519–523 (2008).
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